|Articles|July 1, 2000

Overactive Bladder: Examining the Burden of Disease
Volume 6
Issue 11 Suppl

Discussion

Download PDF: Discussion

Articles in this issue

about 26 years ago

Article

Overactive Bladder: Special Considerations in the Geriatric Population

about 26 years ago

Article

Bibliography

about 26 years ago

Article

Participating Faculty

about 26 years ago

Article

Introduction: Overactive Bladder - Defining the Disease

about 26 years ago

Article

The Prevalence of Overactive Bladder

about 26 years ago

Article

Comorbidities Associated with Overactive Bladder

about 26 years ago

Article

Overactive Bladder Significantly Affects Overall Quality of Life

about 26 years ago

Article

Economic Considerations in Overactive Bladder

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Content

The Timing and Characteristics of Supplemental Indications for Medicines

ByYingying Zhu, PhD,Claire H. Brennan, BA,Haijun Tian, PhD,Josephine N. Tran, PharmD, MS,Peter J. Neumann, ScD,James D. Chambers, PhD,Pei-Jung Lin, PhD,Meng Li, PhD

July 6th 2026

State Medicaid Budgetary Implications of New Cancers

ByAmanda C. Chen, PhD,Anuraag R. Kansal, PhD,David C. Grabowski, PhD

July 2nd 2026

Blood Pressure Control Among Adherent vs Nonadherent Medicare Patients With Hypertension

ByKaitlyn T. Haas, PharmD,Joseph J. Saseen, PharmD, BCPS, BCACP,Oliver Titus, MS,Nathan Lamberton, PharmD, BCACP,Lisa M. Schilling, MD, MSPH,Keri N. Hogan, PharmD, BCACP,Alison Marks, BA,Sarah J. Billups, PharmD, BCPS

July 1st 2026

The Effect of Medicaid Reimbursement for Psychiatrists on the Health Care Burden of Serious Mental Illness

ByOnur Baser, PhD, MS,Heidi C. Waters, PhD,Nehir Yapar, BS,Gabriela Samayoa, MD, MPH,Xue Han, PhD,Deborah Freedman, MBA,Lauren Isenman, MPH,Rashmi Patel, MD, PhD

June 12th 2026

Association of Travel Nursing With Quality Outcomes in Hospitalized Patients

ByJason Bartock, MD,Adam Green, MD,Raquel Nahra, MD,Amy Bordogna, MD,Amir Davoodi, MD,Jean-Sebastien Rachoin, MD

June 11th 2026

Discussion

Articles in this issue

Related Content

The Timing and Characteristics of Supplemental Indications for Medicines

State Medicaid Budgetary Implications of New Cancers

Blood Pressure Control Among Adherent vs Nonadherent Medicare Patients With Hypertension

The Effect of Medicaid Reimbursement for Psychiatrists on the Health Care Burden of Serious Mental Illness

Association of Travel Nursing With Quality Outcomes in Hospitalized Patients

Trending on AJMC

emtelligent Turns Unstructured Clinical Data Into Actionable Insights

Early Treatment Succeeds in CRC With Next-Generation KRAS Inhibitor Calderasib Plus Cetuximab Combo

Real-World Data Show MASH Progresses Faster Than Trials Suggest

Tec-Dara Shows MRD-Negative, PFS Benefit in High-Risk Myeloma, but Longer Follow-Up Needed: Rahul Banerjee, MD

FDA Advisory Committee Supports Moderna mRNA Flu Vaccine Review

Access, Affordability, & Accountability: A New Era in Oncology Reimbursement

Discussion

Articles in this issue

Related Content

The Timing and Characteristics of Supplemental Indications for Medicines

State Medicaid Budgetary Implications of New Cancers

Blood Pressure Control Among Adherent vs Nonadherent Medicare Patients With Hypertension

The Effect of Medicaid Reimbursement for Psychiatrists on the Health Care Burden of Serious Mental Illness

Association of Travel Nursing With Quality Outcomes in Hospitalized Patients

Trending on AJMC

emtelligent Turns Unstructured Clinical Data Into Actionable Insights

Early Treatment Succeeds in CRC With Next-Generation KRAS Inhibitor Calderasib Plus Cetuximab Combo

Real-World Data Show MASH Progresses Faster Than Trials Suggest

Tec-Dara Shows MRD-Negative, PFS Benefit in High-Risk Myeloma, but Longer Follow-Up Needed: Rahul Banerjee, MD

FDA Advisory Committee Supports Moderna mRNA Flu Vaccine Review